Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals is in the business of manufacturing, producing, developing and marketing a wide range of branded Pharmaceuticals and health care products.

Pros:
Company has reduced debt.
Company is virtually debt free.
Company has good consistent profit growth of 22.57% over 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 29.15%
Company has been maintaining a healthy dividend payout of 27.65%
Cons:
The company has delivered a poor growth of 10.58% over past five years.

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Formulations

Loading peers table ...

Quarterly Results Figures in Rs. Crores

Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018
21.98 22.30 28.69 24.91 27.40 16.99 36.75 30.87 30.06 23.26 31.98 32.28
19.27 19.55 21.76 20.54 21.71 20.56 24.35 24.41 21.55 20.66 24.90 25.91
Operating Profit 2.71 2.75 6.93 4.37 5.69 -3.57 12.40 6.46 8.51 2.60 7.08 6.37
OPM % 12.33% 12.33% 24.15% 17.54% 20.77% -21.01% 33.74% 20.93% 28.31% 11.18% 22.14% 19.73%
Other Income 0.88 0.73 0.63 0.66 0.89 1.11 0.94 0.69 0.65 0.91 0.90 0.67
Interest 0.12 0.09 0.11 0.09 0.13 0.09 0.09 0.11 0.13 0.09 0.09 0.11
Depreciation 0.55 0.44 0.45 0.45 0.45 0.36 0.38 0.38 0.38 0.32 0.33 0.35
Profit before tax 2.92 2.95 7.00 4.49 6.00 -2.91 12.87 6.66 8.65 3.10 7.56 6.58
Tax % 55.82% 33.90% 27.71% 34.08% 41.00% 1.03% 22.53% 31.83% 35.49% 12.90% 24.07% 32.07%
Net Profit 1.29 1.95 5.06 2.95 3.53 -2.88 9.97 4.54 5.58 2.70 5.74 4.46
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Figures in Rs. Crores

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 TTM
35.41 38.39 42.41 51.40 56.91 59.82 69.35 76.22 85.21 93.58 103.31 114.67 117.58
32.23 34.99 38.40 44.95 46.69 50.26 59.44 64.70 69.95 77.12 83.59 90.88 93.02
Operating Profit 3.18 3.40 4.01 6.45 10.22 9.56 9.91 11.52 15.26 16.46 19.72 23.79 24.56
OPM % 8.98% 8.86% 9.46% 12.55% 17.96% 15.98% 14.29% 15.11% 17.91% 17.59% 19.09% 20.75% 20.89%
Other Income 0.45 0.43 0.50 0.68 0.41 0.82 1.34 1.63 2.10 2.74 2.96 3.39 3.13
Interest 0.93 1.04 0.94 0.58 0.55 0.63 0.94 1.27 0.36 0.38 0.41 0.41 0.42
Depreciation 0.67 0.64 0.67 0.82 0.99 1.22 1.48 1.55 2.66 1.99 1.79 1.50 1.38
Profit before tax 2.03 2.15 2.90 5.73 9.09 8.53 8.83 10.33 14.34 16.83 20.48 25.27 25.89
Tax % 40.89% 39.53% 43.79% 34.03% 33.77% 29.66% 29.56% 27.30% 32.78% 35.95% 34.03% 31.86%
Net Profit 1.20 1.30 1.63 3.78 6.02 6.00 6.22 7.51 9.65 10.78 13.51 17.21 18.48
EPS in Rs 2.37 2.58 3.20 7.61 12.37 12.30 12.69 15.32 19.47 21.72 29.05 37.50
Dividend Payout % 48.44% 44.71% 51.35% 36.90% 27.03% 27.13% 31.40% 31.58% 30.36% 31.06% 27.88% 24.00%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:11.56%
5 Years:10.58%
3 Years:10.40%
TTM:4.97%
Compounded Profit Growth
10 Years:29.96%
5 Years:22.57%
3 Years:21.28%
TTM:21.90%
Return on Equity
10 Years:31.06%
5 Years:29.66%
3 Years:29.15%
Last Year:29.70%

Balance Sheet Figures in Rs. Crores

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Sep 2018
4.65 4.65 4.65 4.65 4.65 4.65 4.65 4.65 4.65 4.65 4.65 4.59 4.59
Reserves 2.57 3.16 3.60 5.68 9.91 14.05 18.00 22.66 28.79 35.54 49.79 56.67 61.68
Borrowings 9.00 9.53 6.95 4.87 2.18 2.38 4.64 2.04 6.63 5.42 6.37 0.25 3.30
9.26 8.22 10.60 11.43 19.11 19.28 21.71 14.59 20.77 12.55 15.72 16.35 16.41
Total Liabilities 25.48 25.56 25.80 26.63 35.85 40.36 49.00 43.94 60.84 58.16 76.53 77.86 85.98
6.30 6.09 6.45 7.36 10.27 13.11 14.23 13.57 11.60 12.11 10.63 9.57 10.23
CWIP 0.00 0.00 0.97 1.05 0.52 0.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.63 0.39 0.48 0.57 0.79 0.53 0.31 0.31 0.31 0.61 1.94 5.42 5.24
18.55 19.08 17.90 17.65 24.27 26.48 34.46 30.06 48.93 45.44 63.96 62.87 70.51
Total Assets 25.48 25.56 25.80 26.63 35.85 40.36 49.00 43.94 60.84 58.16 76.53 77.86 85.98

Cash Flows Figures in Rs. Crores

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
1.41 0.53 4.43 4.74 7.33 6.92 4.54 11.43 8.69 7.82 9.95 16.18
-1.60 -0.18 -0.97 -0.59 -3.22 -2.84 -1.14 0.44 1.24 -0.27 -9.77 1.00
-0.07 -0.15 -3.55 -3.71 -2.19 -1.66 0.08 -6.53 0.83 -5.42 0.68 -17.98
Net Cash Flow -0.26 0.20 -0.09 0.44 1.92 2.42 3.48 5.34 10.76 2.13 0.86 -0.80

Ratios

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
ROCE % 18.02% 18.53% 23.72% 41.58% 60.43% 47.91% 40.36% 40.89% 42.26% 40.15% 39.03% 41.91%
Debtor Days 52.98 47.63 31.41 27.48 30.53 22.45 31.68 26.24 31.61 22.54 32.04 39.92
Inventory Turnover 5.64 5.44 6.11 8.21 10.09 9.90 9.91 10.72 12.10 11.83 10.88 13.07

Recent Announcements

View all announcements

Annual Reports

Credit Ratings